A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

BACKGROUND: Ramucirumab has recently proved to be effective for advanced or recurrent gastric cancer (AGC). Ascites and peritoneal metastasis are among the most common complications of AGC. However, there are few data on the safety and efficacy of paclitaxel plus ramucirumab in patients with AGC wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Hiroshi, Kawazoe, Akihito, Shimada, Kaoru, Fukuoka, Shota, Kuboki, Yasutoshi, Bando, Hideaki, Kojima, Takashi, Ohtsu, Atsushi, Yoshino, Takayuki, Doi, Toshihiko, Shitara, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793350/
https://www.ncbi.nlm.nih.gov/pubmed/29385993
http://dx.doi.org/10.1186/s12885-018-4057-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793350/
https://www.ncbi.nlm.nih.gov/pubmed/29385993
http://dx.doi.org/10.1186/s12885-018-4057-7

Ejemplares similares